Karen-Lise Garm Spindler
5 clinical trials · Sponsor
◉ Watch Karen-Lise Garm Spindler
| Record | Firm | Date |
|---|---|---|
| The ctDNA-RECIST Trial Part One (NCT06562348) | Karen-Lise Garm Spindler | 2025-01-15 |
| OPTIMIzation of Treatment SElection and Follow up in Oligometastatic Colorectal Cancer (NCT04680260) | Karen-Lise Garm Spindler | 2021-10-25 |
| Bone-sparing Chemoradiotherapy for Anal Cancer - DACG-II (NCT05385250) | Karen-Lise Garm Spindler | 2021-08-23 |
| IMPROVE Intervention Trial Implementing Non-invasive Circulating Tumor DNA Analysis to Optimize the Operative and Postoperative Treatment for Patients With Colorectal Cancer (NCT03748680) | Karen-Lise Garm Spindler | 2018-10-01 |
| OPTImal PALliative Anti-epidermal Growth Factor Receptor Treatment in Metastatic Colorectal Cancer - (NCT03750175) | Karen-Lise Garm Spindler | 2018-06-01 |
Track Karen-Lise Garm Spindler automatically
Every clearance here is in the API, with alerts when new ones post.